Brokerages Set HCA Healthcare, Inc. (NYSE:HCA) Price Target at $387.13

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) has received an average recommendation of "Moderate Buy" from the eighteen research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, eleven have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $387.13.

Several analysts have recently issued reports on HCA shares. KeyCorp decreased their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Truist Financial lifted their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, August 19th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Finally, Barclays reduced their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating on the stock in a research report on Friday, November 8th.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company's stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock valued at $5,608,990. Corporate insiders own 1.70% of the company's stock.

Institutional Investors Weigh In On HCA Healthcare

A number of large investors have recently modified their holdings of the business. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare in the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare in the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after buying an additional 71 shares during the last quarter. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth about $33,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $39,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

NYSE:HCA traded down $1.56 during trading hours on Wednesday, reaching $315.23. The stock had a trading volume of 882,105 shares, compared to its average volume of 1,201,990. The company has a 50 day moving average price of $360.32 and a two-hundred day moving average price of $358.90. HCA Healthcare has a 52 week low of $260.79 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a market capitalization of $79.85 billion, a PE ratio of 14.22, a PEG ratio of 1.23 and a beta of 1.63.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.84%. HCA Healthcare's dividend payout ratio is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.